despite the benefit ( albeit limited ) shown by the early trials of zidovudine in patients with acquired immune deficiency syndrome ( aids ) , there is general agreement that the best prospects for therapeutic intervention lie in the use of agents early in the infectious process .
C0043474
zidovudine
C0001175
acquired immune deficiency syndrome